Ozge Ilhan-Sarac1, Esen Karamursel Akpek. 1. The Ocular Surface Diseases and Dry Eye Clinic, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-9238, USA.
Abstract
PURPOSE OF REVIEW: Diseases affecting the cornea are a major cause of blindness worldwide, second only to cataract in overall importance, with an estimated 10 to 15 million affected people. Although keratoplasty is by far the most successful transplantation surgery, the outcomes in high-risk adult patients, including those with ocular surface diseases and multiple graft rejections, and in pediatric patients with congenital corneal opacities are disappointing. RECENT DEVELOPMENTS: Regrettably, no significant clinical developments have been achieved in the field of corneal transplantation since the introduction of steroids for graft rejection. Furthermore, obtaining donor corneal tissues and eye banking, particularly in the developing countries where corneal blindness is most prevalent, are problematic. Although the postoperative complications may be severe and limit the use of currently available devices, keratoprosthesis--artificial corneal implantation--has a role in the management of corneal blindness in carefully selected patients with complex ocular diseases who are at high risk for graft failure. SUMMARY: This article reviews the recent ophthalmic literature published on the current concepts and techniques of keratoprosthesis surgery.
PURPOSE OF REVIEW: Diseases affecting the cornea are a major cause of blindness worldwide, second only to cataract in overall importance, with an estimated 10 to 15 million affected people. Although keratoplasty is by far the most successful transplantation surgery, the outcomes in high-risk adult patients, including those with ocular surface diseases and multiple graft rejections, and in pediatric patients with congenital corneal opacities are disappointing. RECENT DEVELOPMENTS: Regrettably, no significant clinical developments have been achieved in the field of corneal transplantation since the introduction of steroids for graft rejection. Furthermore, obtaining donor corneal tissues and eye banking, particularly in the developing countries where corneal blindness is most prevalent, are problematic. Although the postoperative complications may be severe and limit the use of currently available devices, keratoprosthesis--artificial corneal implantation--has a role in the management of corneal blindness in carefully selected patients with complex ocular diseases who are at high risk for graft failure. SUMMARY: This article reviews the recent ophthalmic literature published on the current concepts and techniques of keratoprosthesis surgery.
Authors: Brian D Lawrence; Jeffrey K Marchant; Mariya A Pindrus; Fiorenzo G Omenetto; David L Kaplan Journal: Biomaterials Date: 2008-12-06 Impact factor: 12.479
Authors: Emily A Gosselin; Tess Torregrosa; Chiara E Ghezzi; Alexandra C Mendelsohn; Rachel Gomes; James L Funderburgh; David L Kaplan Journal: J Tissue Eng Regen Med Date: 2017-09-28 Impact factor: 3.963
Authors: Gang Li; Yi Li; Guoqiang Chen; Jihuan He; Yifan Han; Xiaoqin Wang; David L Kaplan Journal: Adv Healthc Mater Date: 2015-03-13 Impact factor: 9.933
Authors: David Myung; Nabeel Farooqui; Luo Luo Zheng; Wongun Koh; Sarita Gupta; Amit Bakri; Jaan Noolandi; Jennifer R Cochran; Curtis W Frank; Christopher N Ta Journal: J Biomed Mater Res A Date: 2009-07 Impact factor: 4.396
Authors: Wei Zhong; Mario Montana; Samuel M Santosa; Irene D Isjwara; Yu-Hui Huang; Kyu-Yeon Han; Christopher O'Neil; Ashley Wang; Maria Soledad Cortina; Jose de la Cruz; Qiang Zhou; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar Journal: Surv Ophthalmol Date: 2017-12-27 Impact factor: 6.048